It inhibits the palmitoylation of endogenous PD-L1 by competitively binding DHHC3 enzyme, reduced the level of PDL1 expression in tumor cells, and enhanced T cell-mediated anti-tumor immune responses. This evidence concerns the gene ZDHHC3 and neoplasm.